Newly defined biomarker may accelerate clinical trials for vaccines to prevent HIV-1 infection - Medical Xpress
8/22/2022 12:00:00 AM2 years 8 months ago
by Science X staff
by Science X staff
A study published in the Aug. 22, 2022, issue of Nature Medicine identifies a new biomarker that appears effective as a surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent acquisition of HIV-1, the most …
A study published in the Aug. 22, 2022, issue of Nature Medicine identifies a new biomarker that appears effective as a surrogate endpoint to reliably predict the ability of broadly neutralizing mono… [+7796 chars]
full article...